SGCD: A Protein Involved in ECM Formation and Disease Development

Target Name: SGCD

NCBI ID: G6444

SGCD

SGCD: A Protein Involved in ECM Formation and Disease Development

SGCD (Dystrophin Associated Glycoprotein, Delta Sarcoglycan) is a protein that is expressed in various tissues throughout the body, including the skin, heart, kidneys, and lungs. It is a key component of the extracellular matrix (ECM), which is a complex tissue-cell intercellular structure that plays a vital role in maintaining tissue repair, growth, and function. SGCD is also known as dystrophin, a protein that is essential for the survival of many cell types, including those that line the skin and other organs.

SGCD is a glycoprotein, which means that it consists of a protein that is composed of both protein and glycine. It is expressed in a variety of tissues throughout the body and is involved in the formation of the ECM. SGCD is one of the proteins that make up the dystrophin complex, which is a group of proteins that work together to help maintain the integrity of the skin and other organs.

SGCD is a key protein for the formation of the dystrophin-like structure (DS), which is a component of the ECM that helps to provide support and structure to tissues. The DS helps to hold cells in place and helps to regulate the movement of cells and other ECM components.

SGCD is also involved in the regulation of the immune response and has been shown to play a key role in the development and progression of a variety of diseases, including cancer. It is thought to do this by helping to facilitate the movement of immune cells to the site of infection or inflammation, and by participating in the regulation of the production of antibodies.

SGCD is also a potential drug target and has been shown to be involved in a variety of biological processes that are important for human health. For example, studies have shown that SGCD is involved in the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also thought to be involved in the regulation of the immune response and has been shown to play a key role in the development of autoimmune diseases.

In addition to its potential as a drug target, SGCD is also a potential biomarker for a variety of diseases. Its expression is often abnormal in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes it a potential indicator of the presence of these diseases and could be used for diagnostic purposes.

Overall, SGCD is a protein that is involved in a variety of important biological processes and is thought to be involved in the development and progression of a variety of diseases. Its potential as a drug target and biomarker make it an attractive target for research in these areas. Further studies are needed to fully understand its role in these processes and to develop effective treatments for the diseases that are associated with its abnormal expression.

Protein Name: Sarcoglycan Delta

Functions: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix

The "SGCD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SGCD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets